UTHR UNITED THERAPEUTICS CORP
2026Q1 · CUSIP 91307C102 · Sector: Healthcare & Biotech
Cooling · Breadth rolling over
Holders
841
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
281
Δ whales
-2
Inst. holding value
$24.4B
New positions
114
Closed positions
103
Price momentum (1Q)
+17.5%
Put / Call
21/20
Breadth history (34 quarters)
Past Lit Events & Aftermath 14 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 3% | +17.5% | — |
| 2025Q3 | Top 8% | +1.8% | +19.5% |
| 2024Q4 | Top 10% | -18.1% | -16.0% |
| 2024Q3 | Top 3% | +0.5% | -14.1% |
| 2024Q2 | Top 4% | +20.3% | +18.6% |
| 2023Q4 | Top 20% | +27.7% | +62.3% |
| 2023Q3 | Top 3% | -5.5% | +21.2% |
| 2022Q4 | Top 6% | -13.8% | -8.6% |
Options Sentiment
Put holders
21
QoQ: +9
Call holders
20
QoQ: +9
See methodology →
Fundamentals
PE (TTM)
19.6
EPS (TTM)
$27.05
EPS YoY
+7.8%
Revenue (TTM)
$3.2B
Revenue YoY
+5.9%
Net margin
40.6%
ROE
21.8%
Debt ratio
12.1%
FCF (TTM)
$1.0B
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.